<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03317704</url>
  </required_header>
  <id_info>
    <org_study_id>SET-NAC</org_study_id>
    <nct_id>NCT03317704</nct_id>
  </id_info>
  <brief_title>Regulation of Metabolism and Ion Handling</brief_title>
  <official_title>Regulation of Metabolism and Ion Handling - Effect of High Intensity Training and NAC-infusion in Young Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Morten Hostrup, PhD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Copenhagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the relation between ion-handling (K+) and fatigue development during&#xD;
      exercise. Before and after a 6-week period of high intensity interval training, performance&#xD;
      and ion-handling is assessed in young adults. In addition, mitochondrial function is&#xD;
      examined.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 25, 2017</start_date>
  <completion_date type="Actual">May 20, 2020</completion_date>
  <primary_completion_date type="Actual">December 18, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quadriceps endurance</measure>
    <time_frame>Change from before (baseline) to after 6 weeks of training (Week 6)</time_frame>
    <description>Time to exhaustion during knee-extensor exercise</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>K+ release</measure>
    <time_frame>Change from before (baseline) to after 6 weeks of training (Week 6)</time_frame>
    <description>Net leg K+ release in mmol/min during knee-extensor exercise</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Femoral venous plasma K+</measure>
    <time_frame>Change from before (baseline) to after 6 weeks of training (Week 6)</time_frame>
    <description>Femoral venous plasma K+ in mmol/L during knee-extensor exercise</description>
  </other_outcome>
  <other_outcome>
    <measure>Femoral venous lactate</measure>
    <time_frame>Change from before (baseline) to after 6 weeks of training (Week 6)</time_frame>
    <description>Femoral venous lactate in mmol/L during knee-extensor exercise</description>
  </other_outcome>
  <other_outcome>
    <measure>Muscle Na+/K+-ATPase subunit content</measure>
    <time_frame>Change from before (baseline) to after 6 weeks of training (Week 6)</time_frame>
    <description>Muscle Na+/K+-ATPase subunit content from vastus lateralis biopsies</description>
  </other_outcome>
  <other_outcome>
    <measure>Muscle mitochondrial respiration</measure>
    <time_frame>Change from before (baseline) to after 6 weeks of training (Week 6)</time_frame>
    <description>Muscle mitochondrial respiration by high resolution respirometry (flux per mg muscle) from vastus lateralis biopsies</description>
  </other_outcome>
  <other_outcome>
    <measure>Muscle mitochondrial content</measure>
    <time_frame>Change from before (baseline) to after 6 weeks of training (Week 6)</time_frame>
    <description>Muscle mitochondrial content of citrate synthase from vastus lateralis biopsies</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>speed endurance training (SET)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Training 6 weeks 3 times pr. week</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Asked to continue their usual life style</description>
  </arm_group>
  <arm_group>
    <arm_group_label>speed endurance training (SET) II</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Training 6 weeks 3 times pr. week</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Speed endurance training</intervention_name>
    <description>Speed endurance training</description>
    <arm_group_label>speed endurance training (SET)</arm_group_label>
    <arm_group_label>speed endurance training (SET) II</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy men&#xD;
&#xD;
          -  45-55 ml/kg/min&#xD;
&#xD;
          -  BMI 19-26 kg/m2&#xD;
&#xD;
          -  Normal ECG (assessed by MD)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Allergic to n-acetylcystine (NAC) or digoxin&#xD;
&#xD;
          -  Severe side effects from NAC or digoxin&#xD;
&#xD;
          -  Chronic diseases (assessed by MD to be a potential hazard or to interfere with outcome&#xD;
             measures)&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Copenhagen</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>October 3, 2017</study_first_submitted>
  <study_first_submitted_qc>October 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 23, 2017</study_first_posted>
  <last_update_submitted>September 9, 2020</last_update_submitted>
  <last_update_submitted_qc>September 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Copenhagen</investigator_affiliation>
    <investigator_full_name>Morten Hostrup, PhD</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

